Form 4: BiomX Inc. Director Gregory Louis Merril Acquires Options in Company

Director Gregory Louis Merril reports acquisition of options to purchase 17,600 shares of BiomX Inc. common stock.

Summary

• Gregory Louis Merril, a director of BiomX Inc., filed a Form 4 disclosing a transaction involving derivative securities.
• On April 14, 2025, Merril acquired options to purchase 17,600 shares of BiomX Inc. common stock at an exercise price of $0.538.
• The options vest over four years, with 25% vesting on April 14, 2026, and the remainder vesting in 12 equal quarterly installments over three years.
• Following the reported transaction, Merril directly owns options for 17,600 shares.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock option grants to a director, neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.

Stakeholder Impact

• The acquisition of options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Form 4, BiomX Inc., Director, Options, Gregory Louis Merril, Beneficial Ownership, PHGE, Stock Options, Vesting